Malonic Acid

Malonic Acid

SCHEMBL1764322

CCN(CC)C(C)=O.O=C(O)CC(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.47
SRR Q9GZT4 1/20 0.47
ALDH1A1 P00352 3/20 0.42
ALDH2 P05091 1/20 0.42
LMNA P02545 3/20 0.39
FFAR3 O14843 2/20 0.38
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP8 P22894 1/20 0.37
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
HPGD P15428 2/20 0.32
MAPT P10636 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL27573497 0.86 FFAR3 (0.44) ALDH1A1ALDH2LMNAFFAR3MMP1
SCHEMBL18738 0.86
SCHEMBL6273224 0.86
Benzene SCHEMBL4101064 0.83 LMNA (0.45) ALDH1A1LMNAMMP1MMP2MMP3
Hydrochloric Acid SCHEMBL668539 0.83
Iodide SCHEMBL15299863 0.83
Ammonia Solution, Strong SCHEMBL28075387 0.83
Acetic Acid SCHEMBL28859591 0.81 LMNA (0.40) ALDH1A1ALDH2LMNAFFAR3MMP1
SCHEMBL288074 0.80 LMNA (0.43) ALDH1A1ALDH2LMNAMMP1MMP2
SCHEMBL2904619 0.80 ALDH1A1 (0.59) ALDH1A1ALDH2LMNAFFAR3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-11343300-A None JP disclosed
CN-111433577-A Temperature detection label and article management device using same 株式会社日立制作所 2020-07-17 CN disclosed
CN-111057001-A Preparation method of quinolone malonate compound 巨化集团公司制药厂 2020-04-24 CN disclosed
WO-2019142480-A1 TEMPERATURE DETECTION INK, TEMPERATURE DETECTION INK INITIALIZATION METHOD, TEMPERATURE INDICATOR, AND ARTICLE MANAGEMENT SYSTEM 株式会社日立製作所 2019-07-25 WO disclosed
WO-2019142485-A1 TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME 株式会社日立製作所 2019-07-25 WO disclosed
EP-2319850-B1 OPTICALLY ACTIVE alpha-AMINO ACID INTO WHICH BSH IS INTRODUCED AND METHOD FOR SYNTHESIZING THE SAME STELLA PHARMA CORP (JP) 2017-03-29 EP disclosed
US-8431738-B2 Optically active α-amino acid into which BSH is introduced and method for synthesizing the same STELLA PHARMA CORPORATION (JP) 2013-04-30 US disclosed
US-20110124914-A1 OPTICALLY ACTIVE ALPHA-AMINO ACID INTO WHICH BSH IS INTRODUCED AND METHOD FOR SYNTHESIZING THE SAME STELLA PHARMA CORPORATION (JP) 2011-05-26 US disclosed
EP-2319850-A1 OPTICALLY ACTIVE -AMINO ACID INTO WHICH BSH IS INTRODUCED AND METHOD FOR SYNTHESIZING THE SAME Stella Pharma Corporation (JP) 2011-05-11 EP disclosed
US-7718805-B2 Process for preparing rebamipide OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-05-18 US disclosed
US-6384063-B1 Compound having effect of promoting neuron differentiation NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2002-05-07 US disclosed
US-6284915-B2 Process for preparing 2-amino malonic acid derivatives and 2-amino-1,3-propanediol derivatives, and intermediates for preparing the same TAITO CO., LTD (JP) 2001-09-04 US disclosed
US-20010008945-A1 PROCESS FOR PREPARING 2-AMINO MALONIC ACID DERIVATIVES AND 2-AMINO-1,3 - PROPANEDIOL DERIVATIVES, AND INTERMEDIATES FOR PREPARING THE SAME MITSUBISHI PHARMA CORPORATION (JP) 2001-07-19 US disclosed
EP-0999204-A1 NOVEL COMPOUND HAVING EFFECT OF PROMOTING NEURON DIFFERENTIATION Nippon Kayaku Kabushiki Kaisha (JP) 2000-05-10 EP disclosed
EP-0989113-A1 PROCESSES FOR PRODUCING 2-AMINOMALONIC ACID DERIVATIVES AND 2-AMINO-1,3-PROPANEDIOL DERIVATIVES, AND INTERMEDIATES FOR PRODUCING THE DERIVATIVES TAITO CO., LTD. (JP) 2000-03-29 EP disclosed
JP-H11343300-A NEW HAPTEN, ANTIBODY RECOGNIZING THE HAPTEN AND IMMUNOLOGICAL DETERMINATION USING THE SAME FUJITA TETSURO 1999-12-14 JP disclosed
US-5652232-A VIRICIDES, TREATMENT OF RETROVIRUS INFECTIOUS DISEASE; AIDS SHIONOGI & CO., LTD. (JP) 1997-07-29 US disclosed
CN-1033651-C Process for producing trans -L- hydroxyproline. KYOWA HAKKO KOGYO KK (JP) 1996-12-25 CN disclosed
EP-0721945-A1 BENZOLACTAM DERIVATIVE SHIONOGI & CO., LTD. (JP) 1996-07-17 EP disclosed
CN-1072211-A The preparation method of trans-L-hydroxyproline KYOWA HAKKO KOGYO KK (JP) 1993-05-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008945-A1 PROCESS FOR PREPARING 2-AMINO MALONIC ACID DERIVATIVES AND 2-AMINO-1,3 - PROPANEDIOL DERIVATIVES, AND INTERMEDIATES FOR PREPARING THE SAME BCAT2, BCAT1, BCKDK LDHA 223/4885SRR 487/4885ALDH1A1 108/4885
US-20110124914-A1 OPTICALLY ACTIVE ALPHA-AMINO ACID INTO WHICH BSH IS INTRODUCED AND METHOD FOR SYNTHESIZING THE SAME BCAT1, BCAT2, CTH LDHA 2087/4885SRR 163/4885ALDH1A1 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.